According to Insilicon Smart, Insilicon Smart and Mozu Biotech signed a strategic cooperation agreement today. The two sides will develop deep collaboration around the production, integration and application of high-quality, traceable, and AI-ready single-cell data. Multiomics data produced on a large scale by Mozhuo Biotech will be systematically injected into the data warehouse of the Insilix Smart Pharma.ai platform to provide training, verification and model iteration support for its core generative biology platform PandaOmics and the newly released multi-agent driven virtual senescence cell platform.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.